MULTIPLE MYELOMA (MM)
Clinical trials for MULTIPLE MYELOMA (MM) explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE MYELOMA (MM) trials appear
Sign up with your email to follow new studies for MULTIPLE MYELOMA (MM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat myeloma? early trial ends early
Disease control TerminatedThis early-phase study tested a new drug called WVT078, alone or with another drug (WHG626), in people with multiple myeloma that returned or didn't respond to prior treatments. The main goal was to find a safe dose and check for side effects. The study was stopped early, so resu…
Matched conditions: MULTIPLE MYELOMA (MM)
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New drug duo targets Hard-to-Treat blood cancers
Disease control TerminatedThis study tested two experimental drugs, VOB560 and MIK665, given together to people with certain blood cancers (non-Hodgkin lymphoma, acute myeloid leukemia, or multiple myeloma) that had come back or stopped responding to treatment. The main goals were to find safe doses and s…
Matched conditions: MULTIPLE MYELOMA (MM)
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 13, 2026 16:03 UTC